Wolters Kluwer N.V.

Daten von EODHD, dargestellt in der Berichtswährung; nur zu Informationszwecken, keine Anlageberatung.

Wolters Kluwer N.V. provides information, software solutions, and services for professionals in the Netherlands, rest of Europe, the United States, Canada, the Asia Pacific, and internationally. The company operates through Health; Tax & Accounting; Financial & Corporate Compliance; Legal & Regulatory; and Corporate Performance & ESG segments. The Health segment offers clinical solutions and develops GenAI and agentic solutions to drive better patient care and health outcomes. It serves hospitals, healthcare organizations, clinicians, students, schools, libraries, payers, life sciences, digital health companies, and pharmacies. The Tax & Accounting segment offers AI-powered, cloud-based and on-premise software suites, research solutions to tax and accounting firms; and professional services to support professional workflows, including compliance, audit, and firm management. It also serves businesses, government agencies, and academia. The Financial & Corporate Compliance segment provides financial institutions, corporations, small businesses, and law firms with solutions that enable compliance with ever-changing regulatory and legal obligations, improve efficiency, and help achieve better business outcomes. The Legal & Regulatory segment provides Legal & Regulatory trusted information, insights, and analytics for optimal decisions with accuracy and speed. It serves legal and compliance professionals in law firms, corporate legal departments, universities, and government organizations. The Corporate Performance & ESG segment offers delivers software solutions that support organizations in planning, simulating, and managing financial, sustainability, operational, and risk management activities to drive better outcomes. The company also develops a hosted platform for managing and controlling external legal costs. Wolters Kluwer N.V. was founded in 1836 and is headquartered in Alphen aan den Rijn, the Netherlands.

Noch keine Analysen zu dieser Aktie in Ihrer Sprache.